Markets by TradingView

Browsing Tag

Skye Bioscience

3 posts

Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody

Acquisition of Bird Rock Bio builds Skye’s position as a leading endocannabinoid…

Skye Bioscience Completes Enrollment of Phase 1 Clinical Trial of Novel CB1R Agonist, SBI-100 Ophthalmic Emulsion

SKYE COMPLETES DOSING OF FINAL COHORT OF HEALTHY VOLUNTEERS IN STUDY OF…